Chlorphenamine Maleate API Market

The appearance of chlorpheniramine maleate is a white crystalline solid or white powder, the CAS number is 113-92-8, and the molecular formula is C20H23ClN2O4. Chlorpheniramine maleate preparations are available in tablets and injections.

Chlorphenamine maleate is active ingredient present in antihistamine drugs. It is useful for treating the common cold, flu, hay fever, allergic rhinitis, or other respiratory allergies. The usual symptoms include a runny nose, sneezing, itching, and watery eyes. What makes it stand apart is that, unlike most antihistamines, chlorpheniramine maleate is not so prone to produce drowsiness. This makes chlorpheniramine a suitable ingredient for daytime use.

Chlorphenamine Maleate API Market aims to provide a comprehensive presentation of the global market for Chlorphenamine Maleate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chlorphenamine Maleate API. Chlorphenamine Maleate API Market contains market size and forecasts of Chlorphenamine Maleate API in global, including the following market information:

Global Chlorphenamine Maleate API Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global Chlorphenamine Maleate API Market Sales, 2018-2023, 2024-2029, (Tons)

Global top five Chlorphenamine Maleate API companies in 2022 (%)

The global Chlorphenamine Maleate API market was valued at US$ 67 million in 2022 and is projected to reach US$ 110.4 million by 2029, at a CAGR of 7.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The global top five manufacturers of chlorphenamine maleate API include Henan Jiushi Pharmaceutical, Supriya Lifescience, Kongo Chemical, Amar Healthcare, and Auro Laboratories, with a total market share of about 60%, of which the largest manufacturer is Henan Jiushi Pharmaceutical, with a market share of over 30%. India is the most important producing area of ??chlorpheniramine maleate API in the world, with a market share of more than 45%. In terms of type, the market share with a purity higher than 98% is more than 50%. In the field of application, the market share of tablets is about 60%.

We surveyed the Chlorphenamine Maleate API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chlorphenamine Maleate API Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)

Global Chlorphenamine Maleate API Market Segment Percentages, by Type, 2022 (%)

Purity ?No Higher Than 98%

Purity ?Higher Than 98%

Global Chlorphenamine Maleate API Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)

Global Chlorphenamine Maleate API Market Segment Percentages, by Application, 2022 (%)

Tablets

Injection

Global Chlorphenamine Maleate API Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)

Global Chlorphenamine Maleate API Market Segment Percentages, By Region and Country, 2022 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Chlorphenamine Maleate API revenues in global market, 2018-2023 (Estimated), ($ millions)

Key companies Chlorphenamine Maleate API revenues share in global market, 2022 (%)

Key companies Chlorphenamine Maleate API sales in global market, 2018-2023 (Estimated), (Tons)

Key companies Chlorphenamine Maleate API sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

Henan Jiushi Pharmaceutical

Supriya Lifescience

Kongo Chemical

Amar Healthcare

Keshava Organics

Auro Laboratories

Outline of Major Chapters:

Chapter 1: Introduces the definition of Chlorphenamine Maleate API, market overview.

Chapter 2: Global Chlorphenamine Maleate API market size in revenue and volume.

Chapter 3: Detailed analysis of Chlorphenamine Maleate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Chlorphenamine Maleate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global Chlorphenamine Maleate API capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.